CLINICAL_TRIALS trial_result · 2021-10-08

Clinical Trial Update: Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV Infection [Phase 1]

Phase 1 safety study of a monoclonal antibody against RSV in hospitalized children completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: MedImmune LLC | Conditions: Respiratory Syncytial Virus Prophylaxis | Phase 1 | Status: COMPLETED | Results posted: 2021-10-08